Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Improved hair loss treatment using special particles and surfactants.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Stopping leflunomide healed the woman's skin ulcers.

Six African American women experienced hair loss after switching to a new HIV medication.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib shows promise in treating severe hair loss.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Sorafenib after liver surgery may increase survival for some liver cancer patients.